The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 8478876.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
No consensus exists on the appropriate (set of) endpoints to be reported in rheumatoid arthritis clinical trials. The traditional endpoints are not comprehensive, show overlap, and are insensitive to change. A single, pooled outcome measure or index may be an alternative. However, such an index must be valid and acceptable. An overview of the existing indices suggests several options are available. To date, practical experience with these indices in trials is limited.
Medical subject headings
- Arthritis, Rheumatoid
- Clinical Trials as Topic
- Severity of Illness Index
- Treatment Outcome